Macrogenics Inc
Pharmaceutical company · Rockville, Maryland, United States · Nasdaq: MGNX
Macrogenics Inc is a pharmaceutical company headquartered in Rockville, Maryland, United States. Its shares trade on Nasdaq under the ticker MGNX. It has received 11 US government small-business research awards (SBIR/STTR) from health agencies, $2.6 million in total, most recently in 2004. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2011.
Macrogenics at a glance
What does Macrogenics do?
US government research funding
11 SBIR/STTR small-business research awards from US health agencies, $2.6 million in total (2002 to 2004).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $12 million sold (2011).
Frequently asked questions about Macrogenics
Where is Macrogenics headquartered?
Macrogenics Inc is headquartered in Rockville, Maryland, United States.
What does Macrogenics do?
Macrogenics Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Macrogenics a public company?
Yes. Macrogenics Inc trades on Nasdaq under the ticker MGNX.
Similar companies
- Supernus Pharmaceuticals, Inc.Rockville, Maryland, United States
- Theriva Biologics, Inc.Rockville, Maryland, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.